Lavipharm S.A • LAVI

Capital at risk.

Calendar
event
Ex dividend date
17 Jul 2025
event_available
Last Dividend Payment
08 Nov 1995
About Lavipharm S.A
Ticker
info
LAVI
Trading on
info
AT
ISIN
info
GRS246073001
Industry
info
Drug Manufacturers - Specialty & Generic
Sector
info
Healthcare
CEO
info
Telemaque Jean Lavidas
Headquarters
info
12, Agias Marinas Street, Paiania, undefined, Greece, 19002
Employees
info
269
Website
info
https://lavipharm.com
Lavipharm S.A. engages in the research, development, manufacturing, import, marketing, sale, and wholesaling of pharmaceutical, dermocosmetic, and healthcare products in Greece and internationally. The company offers pharmaceutical products for cardiology, chronic pain and oncology, central nervous system, respiratory system, gastrointestinal system, and urology; and over the counter (OTC) drugs, such as antiseptics, anagelsics, and anti-lice treatment products. It also provides a range of skincare products focused on health. The company was founded in 1911 and is based in Paiania, Greece.
Metrics
BasicAdvanced
Market cap
info
€139M
P/E ratio
info
82.1
EPS
info
€0.01
Dividend Yield
info
2.47%
Beta
info
0.63
Forward P/E ratio
info
0
EBIDTA
info
€9.5M
Ex dividend date
info
2025-07-17
Price & volume
Market cap
info
€139M
Average daily volume
info
0.2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
€0.02
Dividend yield
info
2.47%
Forward dividend per share
info
€0.02
Forward dividend yield
info
2.44%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
82.1
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
82.1
Price to sales
info
2.54
Price to book
info
2.44
Earnings
EPS
info
€0.01
EPS estimate (current quarter)
info
€0.00
EPS estimate (next quarter)
info
€0.00
EBITDA
info
€9.5M
Revenues (TTM)
info
€54.7M
Revenues per share (TTM)
info
€0.33
Technicals
Beta
info
0.63
52-week High
info
€0.91
52-week Low
info
€0.63
50-day moving average
info
€0.81
200-day moving average
info
€0.81
Short ratio
info
0
Short %
info
0.00%
Management effectiveness
ROE (TTM)
info
3.65%
ROA (TTM)
info
2.68%
Profit margin
info
7.07%
Gross profit margin
info
€24.9M
Operating margin
info
15.50%
Growth
Quarterly earnings growth (YoY)
info
-80.30%
Quarterly revenue growth (YoY)
info
12.90%
Share stats
Outstanding Shares
info
169M
Float
info
64M
Insiders %
info
61.85%
Institutions %
info
1.30%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
€0.08
-
-
Q4 • 06Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
0.00%
Q1 • 23
0.00%
Q2 • 23
NaN%
NaN%
0.00%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
€124M
€72.3M
58.56%
Q2 • 24
€125M
€72.5M
57.79%
Q4 • 24
1.59%
0.24%
-1.32%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
-
-
-
-
Q3 • 23
-
-
-
-
Q1 • 24
-
-
NaN%
NaN%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Lavipharm S.A share?
Collapse

Lavipharm S.A shares are currently traded for undefined per share.

How many shares does Lavipharm S.A have?
Collapse

Lavipharm S.A currently has 169M shares.

Does Lavipharm S.A pay dividends?
Collapse

Yes, Lavipharm S.A does pay dividends.

What is Lavipharm S.A 52 week high?
Collapse

Lavipharm S.A 52 week high is €0.91.

What is Lavipharm S.A 52 week low?
Collapse

Lavipharm S.A 52 week low is €0.63.

What is the 200-day moving average of Lavipharm S.A?
Collapse

Lavipharm S.A 200-day moving average is €0.81.

Who is Lavipharm S.A CEO?
Collapse

The CEO of Lavipharm S.A is Telemaque Jean Lavidas.

How many employees Lavipharm S.A has?
Collapse

Lavipharm S.A has 269 employees.

What is the market cap of Lavipharm S.A?
Collapse

The market cap of Lavipharm S.A is €139M.

What is the P/E of Lavipharm S.A?
Collapse

The current P/E of Lavipharm S.A is 82.1.

What is the EPS of Lavipharm S.A?
Collapse

The EPS of Lavipharm S.A is €0.01.

What is the PEG Ratio of Lavipharm S.A?
Collapse

The PEG Ratio of Lavipharm S.A is null.